Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 6 hours ago

      The first biosimilar to enter the market is Amgen’s Amjevita, which was launched in the US on Jan. 31, 2023. The drug will be available in the US at two different list prices, $3,288 and $1,557 ...